tsh biopharmoration Ltd (8432) — Financial Flexibility Index
tsh biopharmoration Ltd (8432) has a Financial Flexibility Index of 0.17x as of June 2025. Free cash flow of NT$45.82 Million (operating CF NT$42.55 Million minus capex NT$3.27 Million) represents 0% of total liabilities (NT$273.54 Million). Also explore tsh biopharmoration Ltd (8432) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
tsh biopharmoration Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for tsh biopharmoration Ltd across 8 annual periods. Check how strategically is tsh biopharmoration Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for tsh biopharmoration Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for tsh biopharmoration Ltd. For the full company profile including market capitalisation, see tsh biopharmoration Ltd (8432) total market value.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.85x | NT$186.51 Million | NT$183.77 Million | NT$219.22 Million | ▲ +188.3% |
| 2023 | 0.30x | NT$39.43 Million | NT$33.87 Million | NT$133.63 Million | ▲ +23.7% |
| 2022 | 0.24x | NT$53.08 Million | NT$34.35 Million | NT$222.46 Million | ▼ -70.4% |
| 2021 | 0.81x | NT$69.09 Million | NT$68.71 Million | NT$85.80 Million | ▲ +493.1% |
| 2020 | 0.14x | NT$13.99 Million | NT$11.61 Million | NT$103.04 Million | ▼ -79.4% |
| 2019 | 0.66x | NT$91.64 Million | NT$88.65 Million | NT$138.79 Million | ▼ -4.1% |
| 2018 | 0.69x | NT$68.50 Million | NT$62.62 Million | NT$99.44 Million | ▲ +8.6% |
| 2017 | 0.63x | NT$85.70 Million | NT$81.13 Million | NT$135.08 Million | — |